These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10575334)

  • 61. Lung function decline in male heavy smokers relates to baseline airflow obstruction severity.
    Mohamed Hoesein FAA; Zanen P; Boezen HM; Groen HJM; van Ginneken B; de Jong PA; Postma DS; Lammers JJ
    Chest; 2012 Dec; 142(6):1530-1538. PubMed ID: 22722231
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Bronchodilator response of advanced lung function parameters depending on COPD severity.
    Jarenbäck L; Eriksson G; Peterson S; Ankerst J; Bjermer L; Tufvesson E
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2939-2950. PubMed ID: 27932874
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Flow and volume responses after routine salbutamol reversibility testing in mild to very severe COPD.
    Schermer T; Heijdra Y; Zadel S; van den Bemt L; Boonman-de Winter L; Dekhuijzen R; Smeele I
    Respir Med; 2007 Jun; 101(6):1355-62. PubMed ID: 17098407
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics.
    Gelb AF; Flynn Taylor C; Shinar CM; Gutierrez C; Zamel N
    Chest; 2006 Jun; 129(6):1492-9. PubMed ID: 16778266
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Early intervention with inhaled corticosteroids in subjects with rapid decline in lung function and signs of bronchial hyperresponsiveness: results from the DIMCA programme.
    den Otter JJ; van Schayck CP; Folgering HT; van den Boom G; Akkermans RP; van Weel C
    Eur J Gen Pract; 2007; 13(2):89-91. PubMed ID: 17534745
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis.
    Gamble E; Grootendorst DC; Hattotuwa K; O'Shaughnessy T; Ram FS; Qiu Y; Zhu J; Vignola AM; Kroegel C; Morell F; Pavord ID; Rabe KF; Jeffery PK; Barnes NC
    Eur Respir J; 2007 Sep; 30(3):467-71. PubMed ID: 17504799
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of smoking on FEV decline in a cross-sectional and longitudinal study of a large cohort of Japanese males.
    Omori H; Nonami Y; Morimoto Y
    Respirology; 2005 Sep; 10(4):464-9. PubMed ID: 16135169
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials.
    Fabbri LM; Calverley PM; Izquierdo-Alonso JL; Bundschuh DS; Brose M; Martinez FJ; Rabe KF;
    Lancet; 2009 Aug; 374(9691):695-703. PubMed ID: 19716961
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking.
    Nowak D; Kasielski M; Antczak A; Pietras T; Bialasiewicz P
    Respir Med; 1999 Jun; 93(6):389-96. PubMed ID: 10464820
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Molecular diagnosis of intermediate and severe alpha(1)-antitrypsin deficiency: MZ individuals with chronic obstructive pulmonary disease may have lower lung function than MM individuals.
    Dahl M; Nordestgaard BG; Lange P; Vestbo J; Tybjaerg-Hansen A
    Clin Chem; 2001 Jan; 47(1):56-62. PubMed ID: 11148177
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Gender-related differences in severe, early-onset chronic obstructive pulmonary disease.
    Silverman EK; Weiss ST; Drazen JM; Chapman HA; Carey V; Campbell EJ; Denish P; Silverman RA; Celedon JC; Reilly JJ; Ginns LC; Speizer FE
    Am J Respir Crit Care Med; 2000 Dec; 162(6):2152-8. PubMed ID: 11112130
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Bronchodilator responsiveness in patients with COPD.
    Tashkin DP; Celli B; Decramer M; Liu D; Burkhart D; Cassino C; Kesten S
    Eur Respir J; 2008 Apr; 31(4):742-50. PubMed ID: 18256071
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The forgotten message from gold: FVC is a primary clinical outcome measure of bronchodilator reversibility in COPD.
    Ben Saad H; Préfaut C; Tabka Z; Zbidi A; Hayot M
    Pulm Pharmacol Ther; 2008 Oct; 21(5):767-73. PubMed ID: 18555715
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prediction of the rate of decline in FEV(1) in smokers using quantitative Computed Tomography.
    Yuan R; Hogg JC; Paré PD; Sin DD; Wong JC; Nakano Y; McWilliams AM; Lam S; Coxson HO
    Thorax; 2009 Nov; 64(11):944-9. PubMed ID: 19734130
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Retrospective analysis of the relationship between decline in FEV(1) and abdominal circumference in male smokers: the Takahata study.
    Sato M; Shibata Y; Abe S; Inoue S; Igarashi A; Yamauchi K; Aida Y; Kishi H; Nunomiya K; Nakano H; Sato K; Watanabe T; Konta T; Ueno Y; Kato T; Kayama T; Kubota I
    Int J Med Sci; 2013; 10(1):1-7. PubMed ID: 23288999
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils.
    Stănescu D; Sanna A; Veriter C; Kostianev S; Calcagni PG; Fabbri LM; Maestrelli P
    Thorax; 1996 Mar; 51(3):267-71. PubMed ID: 8779129
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Changes in smoking status affect women more than men: results of the Lung Health Study.
    Connett JE; Murray RP; Buist AS; Wise RA; Bailey WC; Lindgren PG; Owens GR;
    Am J Epidemiol; 2003 Jun; 157(11):973-9. PubMed ID: 12777360
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The US Lung Health Study.
    Buist AS
    Respirology; 1997 Dec; 2(4):303-7. PubMed ID: 9525302
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Decline of lung function and development of chronic airflow limitation: a longitudinal study of non-smokers and smokers in Busselton, Western Australia.
    Peat JK; Woolcock AJ; Cullen K
    Thorax; 1990 Jan; 45(1):32-7. PubMed ID: 2321175
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Longitudinal versus cross-sectional vital capacity changes and affecting factors.
    Dontas AS; Jacobs DR; Corcondilas A; Keys A; Hannan P
    J Gerontol; 1984 Jul; 39(4):430-8. PubMed ID: 6610699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.